Data / Form D filings / SENDERO BIOTECHNOLOGY, INC.
SENDERO BIOTECHNOLOGY, INC.: Form D filing
SENDERO BIOTECHNOLOGY, INC., a biotechnology company in Rochester, MI, filed a Form D with the SEC in 2023. The latest, on April 28, 2023, reports $7.3 million sold of a $7.3 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 303 E. THIRD STREET, SUITE 300, Rochester, MI, 48307
- Phone
- (703) 405-9113
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1975410
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 28, 2023 | New notice | $7,336,954 | $7,336,954 | 2 | Apr 15, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Cola | Executive Officer, Director | |
| Andrew Badley | Director | |
| Joshua Barer | Director | |
| Gloria Olivier | Director |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Apr 24, 2023 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SENDERO BIOTECHNOLOGY, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.